- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 9/00 - Drugs for disorders of the cardiovascular system
Patent holdings for IPC class A61P 9/00
Total number of patents in this class: 10665
10-year publication summary
|
308
|
266
|
417
|
543
|
490
|
548
|
567
|
656
|
602
|
571
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Mondobiotech Laboratories AG | 311 |
296 |
| Bayer Pharma AG | 1048 |
119 |
| Novartis AG | 10623 |
108 |
| Bristol-myers Squibb Company | 4820 |
86 |
| Boehringer Ingelheim International GmbH | 4635 |
86 |
| F. Hoffmann-La Roche AG | 7933 |
80 |
| The Regents of the University of California | 20289 |
75 |
| Daiichi Sankyo Company, Limited | 1877 |
72 |
| Osaka University | 3382 |
70 |
| Takeda Pharmaceutical Company Limited | 2717 |
67 |
| AstraZeneca AB | 2858 |
64 |
| Sanofi | 4131 |
59 |
| Bayer AG | 3395 |
47 |
| Amgen Inc. | 4258 |
47 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 2991 |
46 |
| The Johns Hopkins University | 5751 |
44 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3373 |
44 |
| Janssen Pharmaceutica N.V. | 3351 |
38 |
| Hoffmann-La Roche Inc. | 3533 |
37 |
| Cytokinetics, Inc. | 280 |
36 |
| Other owners | 9144 |